The failure of many patients to reach the institute on time has led to significant diagnostic and treatment delays.
These disruptions have the potential to impact the cancer outcome significantly. In the midst of the pandemic, the institute has leveraged the existing molecular diagnostic lab infrastructure, which was initially involved in cervical cancer prevention -- offering the first HPV-DNA-based molecular testing with genotyping, the release said.
CHENNAI, AUGUST 17, 2020 14:46 IST
No comments:
Post a Comment
Hi, feel free to post your comments. Upon Moderation, It will be published here soon.